The Physical Activity Post-Cancer for Adolescents and Young Adults (PAPAYA) trial aims to carry out a pilot randomized controlled trial among 10-17 year-old adolescents and young adults, at least 1 year and up to 5 years post-cancer treatment. The trial will evaluate the effects of a 12 week physical activity intervention to improve patient reported outcomes and physical function, in comparison to a delayed-intervention control group.
The investigators will recruit 40 adolescents and young adults at least 1 year, and up to 5 years post-cancer treatment, and randomize them (20 randomized to each condition) to either a 12-week physical activity intervention to improve patient-reported outcomes and physical function, or delayed-intervention control group. Participants randomized to the intervention group: The physical activity intervention will be structured to increase moderate-to-vigorous intensity aerobic physical activity, to achieve the 60 minute goal, five days per week. The intervention will also include weekly support calls from research staff. The physical activity intervention will be individualized by research staff according to the adolescents and young adults' health status, results from the physical fitness assessment, and most recent week's achieved minutes. The physical activity intervention will be modified during weekly support calls with a study team member, including frequency, intensity, time, and type, to maximize adherence and compliance Participants randomized to the delayed-intervention control group: They will not receive the physical activity intervention, and they will not receive weekly support calls. Physical activity advice according to the Children's Oncology Group Guidelines for Diet and Physical Activity recommendations will be offered to participants randomized to the delayed-intervention control group following completion of 12-week follow-up.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
40
The main structure of the physical activity program will focus on increasing physical activity. Physical activity will initially start at a duration of 15-30 minute bouts, and at rate of perceived exertion levels of 5-6 (somewhat hard). Over the course of the intervention, goals will be set to progress to 60 minutes of continuous physical activity, at a rate of perceived exertion level of 5-6 (somewhat hard). Participants will be instructed on the use of the ratings of the perceived exertion scale (Borg's RPE 1-10 scale). Participants will be instructed to walk, or engage in other forms of leisure-time physical activity to achieve these goals (cycling, running, swimming, etc). As the adolescent and young adults' health and fitness status improve, frequency, intensity, and session duration will be modified accordingly during weekly support calls. Moreover, goals will be responsive to the most recent week's achieved minutes and rate of perceived exertion.
Penn State Health Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
Acceptability-the proportion of adolescents and young adults who agree to participate
The proportion of adolescents and young adults who agree to participate among those deemed eligible by the attending oncologist Range 0-100%-Higher scores indicate greater acceptability
Time frame: Baseline
Feasibility-the proportion of adolescents and young adults who complete at least 50% of the physical activity intervention
The percentage of those randomized to the physical activity intervention that complete at least 50% of the physical activity intervention. Participants will be instructed by a project manager during weekly support calls to accumulate a specific amount of physical activity each week. Participants who self-report completing at least 50% of the physical activity, determined by the Godin-Shephard Leisure-Time Physical Activity Questionnaire, will be deemed compliant. Range 0-100%-Higher scores indicate greater feasibility
Time frame: Baseline to week 12
Patient reported outcomes-physical function mobility
the physical function mobility assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 8-40, higher scores indicate greater physical function mobility
Time frame: Baseline
Patient reported outcomes-physical function mobility
the physical function mobility assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 8-40, higher scores indicate greater physical function mobility
Time frame: week 12
Patient reported outcomes-anxiety
the anxiety assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 8-40, higher scores indicate greater anxiety
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Baseline
Patient reported outcomes-anxiety
the anxiety assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 8-40, higher scores indicate greater anxiety
Time frame: Week 12
Patient reported outcomes-depressive symptoms
the depressive symptoms assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 8-40, higher scores indicate greater depressive symptoms
Time frame: baseline
Patient reported outcomes-depressive symptoms
the depressive symptoms assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 8-40, higher scores indicate greater depressive symptoms
Time frame: Week 12
Patient reported outcomes-fatigue
the fatigue assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 8-40, higher scores indicate greater fatigue
Time frame: baseline
Patient reported outcomes-fatigue
the fatigue assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 8-40, higher scores indicate greater fatigue
Time frame: week 12
Patient reported outcomes-peer relationships
the peer relationships assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 8-40, higher scores indicate greater peer relationships
Time frame: baseline
Patient reported outcomes-peer relationships
the peer relationships assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 8-40, higher scores indicate greater peer relationships
Time frame: week 12
Patient reported outcomes-social isolation
the social isolation assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 8-40, higher scores indicate greater social isolation
Time frame: baseline
Patient reported outcomes-social isolation
the social isolation assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 8-40, higher scores indicate greater social isolation
Time frame: week 12
Patient reported outcomes-pain interference
the pain interference assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 8-40, higher scores indicate greater pain interference
Time frame: baseline
Patient reported outcomes-pain interference
the pain interference assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 8-40, higher scores indicate greater pain interference
Time frame: week 12
Patient reported outcomes-pain intensity
the pain intensity assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 0-10, higher scores indicate greater pain intensity
Time frame: baseline
Patient reported outcomes-pain intensity
the pain intensity assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 0-10, higher scores indicate greater pain intensity
Time frame: week 12
Patient reported outcomes-sleep disturbance
the sleep disturbance assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 8-40, higher scores indicate greater sleep disturbance
Time frame: baseline
Patient reported outcomes-sleep disturbance
the sleep disturbance assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 8-40, higher scores indicate greater sleep disturbance
Time frame: week 12
Patient reported outcomes-cognitive function
the cognitive function assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 7-35, higher scores indicate greater cognitive function
Time frame: baseline
Patient reported outcomes-cognitive function
the cognitive function assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49) Range 7-35, higher scores indicate greater cognitive function
Time frame: week 12
physical function-six minute walking test
The six minute walking test will be administered to assess physical function. Participants will aim to walk as far as possible for 6 minutes. Further distances indicate greater physical function
Time frame: baseline
physical function-six minute walking test
The six minute walking test will be administered to assess physical function. Participants will aim to walk as far as possible for 6 minutes. Further distances indicate greater physical function
Time frame: week 12
physical function-30 second chair stand
The 30 second chair stand test will be administered to assess physical function. Participants will aim to sit and rise out of a chair as many times as possible in 30 seconds. Greater amounts of sit/stands indicate greater physical function
Time frame: baseline
physical function-30 second chair stand
The 30 second chair stand test will be administered to assess physical function. Participants will aim to sit and rise out of a chair as many times as possible in 30 seconds. Greater amounts of sit/stands indicate greater physical function
Time frame: week 12
physical function-timed up and go
The timed up and go test will be administered to assess physical function. Participants will aim to stand up, walk 3 meters, turn around, and walk back to the chair as fast as possible. Shorter durations indicate greater physical function
Time frame: baseline
physical function-timed up and go
The timed up and go test will be administered to assess physical function. Participants will aim to stand up, walk 3 meters, turn around, and walk back to the chair as fast as possible. Shorter durations indicate greater physical function
Time frame: week 12